Blog post
The EU Commission's new draft merger guidelines - key takeaways for pharma companies
On 30 April 2026, the EU Commission published its draft revised EU merger guidelines (Guidelines) which could come into effect by the end of 2026. Whilst in draft form, the Guidelines reflect the direction of travel for the regime, and the Commission has already started to adopt an approach aligned with them. It is therefore important to understand now what this means for deals.
